Boardroom Media (CEO News)
At CEO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Beijing based CEO’ operating in the Health Care space. If you think a CEO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Liangzhi Xie
President and CEO of Sino Biological
Dr. Xie obtained his doctor degree from the Biotechnology Process Engineering Center at Massachusetts Institute of Technology under the supervision of Prof. Daniel I.C. Wang. At MIT, Dr. Xie developed a stoichiometric model to optimize the design of mammalian cell culture medium and the control of the dynamic culture environment. In 1994, he was able to achieve a record cell density of 1.7 x 107 cells/ml and a record antibody titer of 2.4 gram/L. He then worked on viral vaccine process development and cGMP manufacturing for three US FDA approved products (Varicella® , Zostervax® , and ProQuad® ) at Merck Research Laboratory, Merck & Company. He also led the cell culture and viral vaccine process development and cGMP clinical production for Merck’s adenovirus based HIV vaccine and helped to develop by far the largest scale (2000L) of human viral vaccine process under serum-free condition in stirred-tank bioreactors. He is also the director and professor at the Cell Culture R&D center at the Peking Union Medical College since 2002.
Follow Liangzhi Xie:
About Sino Biological, Sinocelltech: Sino Biological is a specialist provider of protein, antibody and gene products.
Yinxiang Wang
CEO and Chairman of Jacobio Pharmaceuticals
Yinxiang WANG graduated from the University of Arkansas for Medical Sciences in 1999, and served as a postdoctoral research fellow at the Department of Molecular Biophysics and Biochemistry of Yale University from 1999 to 2003.He returned to China in 2003 and founded Betta Pharmaceuticals. As the CEO and CSO (2003-2017) of Betta Pharmaceutiacals, YinxiangWang headed the research team, which developed Icotinib Hydrochloride (Conmana), a new molecular entity (NME) for lung cancer. This novel drug is the first small molecule anticancer drug that is completely developed in China and approved by CFDA in 2011. The project won the 1st prize of National Science and Technology Award, the gold medal of WIPO-SIPO Award in 2012 and 2014, and the 1st prize of Science and Technology Award in Zhejiang province. Betta went public at Shenzhen Exchange in 2016.Betta formed JV with Amgen (Amgen-Betta Pharmaceuticals) in 2013 and YinxiangWang served as GM (2013-2017).In 2015, he founded Jacobio Pharmaceuticals and ETown-Jacobio Biocapital in Beijing and serving as the Chairman. Jacobio is focused on innovative drug R&D, especially First-in-Class drugs, and ETown-Jacobio Biocapital as an angel fund to invest early stage R&D of innovative drugs. YinxiangWang is the Chairman, New Drug R&D Committee of China.Pharmaceutical Innovation and Research Development Association (PHIRDA); Associate Chairman,Oncology Drug Clinical Research Committee of Chinese Pharmaceutical Association.YinxiangWang was selected to be the national “Recruitment Program of Global Experts (1000-experts plan)”in 2012.YinxiangWang was selected to be the winner of 2017 CABS K.Fong Award in Life Sciences.
Follow Yinxiang Wang:
About Jacobio Pharmaceuticals: Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company focusing on the development of innovative oncology and other therapies.
Chen Kuan
Founder and CEO of Infervision
Chen Kuan is founder and CEO at Infervision. He is a graduate of the University of Chicago, where he studied under four Nobel Prize winners, Gary Becker, Robert Fogel, James Heckmanm, and Lars Hansen. Chen also studied financial modeling and intelligent modeling in the Double Doctor Degrees Program of Economics and Finance. He founded the company in 2015.
Follow Chen Kuan:
About Infervision: Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Tao He
Founder & CEO of Miaoshou Doctor
Follow Tao He:
About Miaoshou Doctor: Miaoshou Doctor is a health care platform that provides communication services between doctors and patients.
Shirui Wang
Founder and CEO of Medlinker
Graduated from the West China School of Stomatology, Sichuan University, with an eight-year undergraduate, master’s and doctoral degree, and a research scholar at Harvard University. In 2014, Wang Shirui established the Medical Federation. In 2016 and 2018, he was twice selected as the “40 Business Elites under 40 in China” by the Chinese version of Fortune. In 2017 and 2018, he was selected as the “Top Ten New Economic Leaders of Sichuan” twice. In addition, Wang Shirui was also selected as the “Innovative Talent” announced by the Ministry of Science and Technology, and the National “Ten Thousand-Year Plan” Technology Innovation Leading Talent issued by the Organization Department of the CPC Central Committee.
Follow Shirui Wang:
About Medlinker: Medical Alliance is a post of physician social service platform.
Du Bo
Co-Founder and CEO of GeneCast Biotechnology
Du Bo, Co-founder and CEO of Genecast (Beijing) Biotechnology Co., also a member of the Biotech Diagnosis Branch of China Medicinal Biotech Association. As one of the earliest developers to enter the field of NGS in China, Du Bo also co-founded China’s first NGS reagent manufacturer, Quest Genomics (Nanjing) Co., Ltd. Du Bo has accumulated rich experience in investment, pharmaceuticals, and second-generation sequencing, which renders him deep insights in corporate strategic development and management. He has frequently been invited to deliver speeches at conferences in biomedical field, and has won numerous awards, including the prestigious China Pharmaceutical Association’s Technology Progress Award. Du Bo graduated from the department of biology of Peking University.
Follow Du Bo:
About GeneCast Biotechnology: GeneCast Biotechnology is dedicated to improving cancer treatment through precision cancer diagnostics and companion diagnostics.
Xing Li
Founder and CEO of Deep Intelligent Pharma
With over 12 years’experience in drug development in Pfizer, Sanofi, and Johnson & Johnson, she founded the startup in October 2017, aiming to utilize most advanced AI technologies to empower and accelerate the whole drug discovery & development process. In Johnson & Johnson, she built a team of 31 staff from zero and implemented the first AI program in Johnson & Johnson Asia – regulatory document machine translation system – successfully. Xing got her master’s degree from Peking University Health Science Center in pharmaceutics.
Follow Xing Li:
About Deep Intelligent Pharma: Deep Intelligent Pharma is a Beijing based Healthcare company.
Daixing Zhou
CEO of Berry Genomics
Dr. Daixing Zhou is the Chief Executive Officer of Berry Genomics Co., Ltd, located in Beijing, China. Prior to founding Berry Genomics, Dr. Zhou held multiple positions in the next generation sequencing industry, including the Leader of Market Development at Life Technologies Corp., the Head of Sequencing Sales at Illumina-Asia Pacific Japan, and the Director of Bioinformatics at Solexa Inc/Lynx Therapeutics. Dr. Zhou earned his Ph.D. from University of Maryland at Baltimore, and completed his postdoctoral training at Duke University.
Follow Daixing Zhou:
About Berry Genomics: Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.
Ma Xuguang
Co-Founder and CEO of Medbanks
Ma Xuguang is the co-founder and CEO of Medbanks.
Follow Ma Xuguang:
About Medbanks: Medbanks is a database platform of clinical and professional medical services for clinical oncology.
Yeqing Zhu
CEO of New Horizon Health
Follow Yeqing Zhu:
About New Horizon Health: New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.
Wei Dong
CEO of EdiGene
Wei Dong has over 20 years of experience in drug development and corporate management in multinational companies . He holds a Ph.D. from Michigan State University, an MBA from Wharton , and a bachelor’s degree from Peking University. He used to be a senior consultant and manager of Deloitte Consulting, providing overall planning and consulting services for biotech companies and pharmaceutical companies. Formerly Senior Director of Johnson & Johnson Innovation Center, responsible for business operations and project management. He used to be Baxalta (later acquired by Shire , now affiliated to Takeda Pharmaceutical), senior director of clinical development in immunotherapy, and global development leader. He has experience in the development, clinical trials and management of a variety of innovative drugs, including Alzheimer’s disease drug development, cancer vaccine research and development, genetic disease orphan drug research and development.
Follow Wei Dong:
About EdiGene: EdiGene is a biotechnology company that develops genome editing technologies.
Weiqi Liu
CEO of UNIMED
Follow Weiqi Liu:
About UNIMED: UNIMED provides integrated medical service models.
Wenting Chen
Chairman and CEO of Laviana Pharma
Follow Wenting Chen:
About Laviana Pharma: Laviana Pharmatech specializes in providing process and manufacture outsourcing services for the pharmaceutical industry.
Yusheng Zhang
Founder & CEO of Apricot Forest
Yusheng Zhang is the founder and chief executive officer of Apricot Trees Information Technology, an entrepreneurial firm focused on the development of mobile tools for medical professionals. Zhang previously served in an American medical big data startup and a medical insurance group that is among the top 500 global corporations. Zhang holds master’s degrees in public health and business administration from Johns Hopkins University. He obtained a PhD in clinical medicine from Peking Union Medical College.
Follow Yusheng Zhang:
About Apricot Forest: Apricot Forest’s mobile app provides doctors with patient records
Duojia Feng
CEO of Beijing Tiantan Biological Products
Duojia Feng is CEO at Beijing Tiantan Biological Products.
Follow Duojia Feng:
About Beijing Tiantan Biological Products: Beijing Tiantan Biological Products Corporation Limited specializes on the biopharmaceutical industry.
Ping Chen
CEO & Founder of Lianluo Smart Ltd.
Ping Chen is a Chief Executive Officer, Director of Lianluo Smart Limited (formely known Dehaier Medical Systems Limited). He was Chairman of the Board, Chief Executive Officer of Dehaier Medical Systems Ltd.
Follow Ping Chen:
About Lianluo Smart Ltd.: Lianluo Smart Ltd. engages in the development, manufacturing, marketing and distribution of medical products.
Ligang Zhang
Founder, Chairman and CEO of iKang Healthcare Group
Zhang Ligang is the founder, Chairman and CEO of iKang Health Group, a provider of private preventive healthcare services in China. Ligang acquired ShanghaiMed Company Limited in 2003 and serves as of Chairman and CEO of the company. His past employers include Sohu, Elong and Shanghai Med Company Limited. Ligang attended Fudan University, Columbia University and Harvard University. He served as President and publisher of Harvard China Review.
Follow Ligang Zhang:
About iKang Healthcare Group: Ikang is a Chinese health management service agency providing personalized health-related services.
Xiangfei Chai
Founder & CEO of Huiyi Huiying
Obtained Postdoctoral fellow in Stanford University, doctor degree in medical physics major in Amsterdam University in Holland. He had studied and worked in the world top medical imaging organizations, such as cancer center of Stanford University, Holland cancer research center and radiology department in Leuven University. He has over 10 years experience on interdisciplinary scientific research and project in the field of Artificial Intelligence, image processing, and data analysis, with the good knowledge of the core technology of image segmentation, identification, analysis and deep learning algorithm. He has been honored “Top 30 AI Start-up entrepreneur” and “Best Youth Model”. Xiangfei Chai also was the the first term trainee of Qingteng University held by Tencent.
Follow Xiangfei Chai:
About Huiyi Huiying: Huiyi Huiying is an international cloud computing & AI tech that has created a digital medical imaging and tumor radiotherapy platform.
Ryan Hua Zhang
CEO of Linkingmed
Dr. Ryan Zhang received his PhD training at the Netherlands Cancer Institute and obtained his BS degree from Southeast University. He has founded three companies before starting Linkingmed in 2016. Dr. Zhang has 8 patents and is involved in 6 research projects funded by provincial natural science funds, including Guangdong Natural Science Foundation (No. 2014A030313146), Guangdong Natural Science Foundation (2016A030313302), Sichuan Applied Basic Research Program (key project, No. 2018GZ0197). He has published 7 SCI papers and 8 international conference papers in peer-reviewed journals such as Radiotherapy & Oncology, Phys Med Biol, and Med Phys. He received the 2012 Best Clinical Research Award from the Dutch Cancer Forum, 2014 SIAM (Science and Applied Mathematics Association) Travel Grant.
Follow Ryan Hua Zhang:
About Linkingmed: Linkingmed is focused on establishing oncology data platform and medical data analysis.
Gang Qin
Founder & CEO of GeneQuantum Healthcare
Gang Qin, Ph.D. is Founder and Chief Executive Officer of GeneQuantum Healthcare.
Follow Gang Qin:
About GeneQuantum Healthcare: GeneQuantum Healthcare is a high-tech company that focuses on the research and development of innovative Bio-therapeutics.
Shana Penna
Founder & CEO of Inmogeia Technologies
Shana is an internationally focused entrepreneur creating technology that makes an impact. Her passion is stimulated by developments in global health technology trends that use emerging technologies like artificial intelligence, robotics, and blockchain. She has dedicated her career to finding the intersection between technology and transformational outcomes. Prior to founding Inmogeia Technologies, Shana was the cofounder of an assistive technology company, Puffin Innovations, which used AI and internet of things connectivity to empower those with severe disabilities. She received an MBA from the prestigious MIT Sloan dual degree program at Tsinghua University in Beijing China.
Follow Shana Penna:
About Inmogeia Technologies: Inmogeia Technologies is a digital platform empowering people to better manage their autoimmune diseases.
Lipson Roberta
President & CEO of Chindex International
Follow Lipson Roberta:
About Chindex International, United Family Healthcare: Chindex International, Inc. provides healthcare services in China.
Depeng Wang
CEO of GrandOmics
As a senior in the field of sequencing, he started the application of Sanger sequencing technology in 2000 and has been engaged in the application of next generation sequencing technology since 2007, including early incubation and promotion of NIPT, PGD/PGS, HLA typing, whole exome sequencing and so on. With the development of third-generation sequencing technology, he started sequencing services based on third-generation sequencing technology in 2012 and initiated and participated in the completion of the first near complete reference Chinese human genome“HuaXia1(HX1)” led by professor Wang kai and Su guohui. Since 2016, he has been engaged in research on Chinese structural variation data and participated in several major research projects based on third-generation sequencing technology.
Follow Depeng Wang:
About GrandOmics: Grandomics provides molecular diagnosis, research, and carrier screening for single gene diseases.
Sharong Li
Founder and CEO of Genedock
Follow Sharong Li:
About Genedock: Genedock is a Healthcare company.
Qiang Cai
Founder and CEO of Saint Lucia Consulting
Qiang Cai is a pioneer in china’s overseas healthcare service industry. He established Beijing Saint Lucia Consulting Pty Ltd. In 2011, china’s first and by far the largest provider of credible guidance on overseas medical care. Currently, he serves as the president and chairman of saint lucia consulting.
Follow Qiang Cai:
About Saint Lucia Consulting: Saint Lucia Consulting provides credible guidance on overseas medical care.
Xin Jin
Founder and CEO of Ayshealth Technology
As the founder and CEO of Beijing Aiyisheng Health Technology Co., Ltd., Mr. Jinxin leads the company’s entrepreneurial team, focusing on the field of chronic disease management, combining artificial intelligence technology with clinical medicine to provide a national guide for artificial intelligence chronic disease management system. The National Medical Reform Demonstration Zone, Beijing Fangzhuang and Shenzhen Luohu, also established a strategic partnership with Ping An Insurance to jointly explore and practice the HMO/PBM chronic disease medical eco-business model. At present, there are more than 100 medical institutions across the country, using Aiyisheng GDS to manage 1 million chronically ill patients. In 2017, the company won the 10th A round of financing of Junlian Capital. Prior to founding Aiyisheng Health, Mr. Jin was responsible for marketing and operations management in China and Greater China, including HP Hewlett-Packard and other leading global high-tech multinational companies. He was the general manager of 3Com China, Ericsson. Senior Director of Ericsson Broadband Business and President of Greater China Networks Redback Networks. Mr. Jin graduated from Shanghai Jiaotong University with a bachelor’s and master’s degree in computer science and technology.
Follow Xin Jin:
About Ayshealth Technology: Ayshealth Technology is a Beijing-based chronic disease management system developer.
Xin Jin
Founder and CEO of Ayshealth Technology
As the founder and CEO of Beijing Aiyisheng Health Technology Co., Ltd., Mr. Jinxin leads the company’s entrepreneurial team, focusing on the field of chronic disease management, combining artificial intelligence technology with clinical medicine to provide a national guide for artificial intelligence chronic disease management system. The National Medical Reform Demonstration Zone, Beijing Fangzhuang and Shenzhen Luohu, also established a strategic partnership with Ping An Insurance to jointly explore and practice the HMO/PBM chronic disease medical eco-business model. At present, there are more than 100 medical institutions across the country, using Aiyisheng GDS to manage 1 million chronically ill patients. In 2017, the company won the 10th A round of financing of Junlian Capital. Prior to founding Aiyisheng Health, Mr. Jin was responsible for marketing and operations management in China and Greater China, including HP Hewlett-Packard and other leading global high-tech multinational companies. He was the general manager of 3Com China, Ericsson. Senior Director of Ericsson Broadband Business and President of Greater China Networks Redback Networks. Mr. Jin graduated from Shanghai Jiaotong University with a bachelor’s and master’s degree in computer science and technology.
Follow Xin Jin:
About Ayshealth Technology: Ayshealth Technology is a Beijing-based chronic disease management system developer.
